Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich Buys Stake in Genospectra as Firms Plan to Co-Develop Cell-Based Assay Tools ...

NEW YORK, Feb. 10 (GenomeWeb News) - Sigma-Aldrich has acquired a minority equity stake in Genospectra and has obtained access to various Genospectra technologies as part of a broad R&D alliance, the companies said today.

 

As part of the deal, the companies said they plan to develop new technology and products in the area of cell-based assays. In particular, the companies aim to develop live-cell biosensor assay reagents that can provide real-time data on the location and activity of proteins in living cells.

 

Other terms of the alliance call for Sigma to gain access to Genospectra's QuantiGene gene expression-profiling assay and its nano-particle system for delivery of siRNA and other biomolecules to cells, called its inducible siRNA technologies.

 

Financial details of the agreement were not disclosed.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.